Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00039364
Status:
COMPLETED
Last Update Posted:
2012-07-24
First Post:
2002-06-06
Brief Title:
Imatinib Mesylate in Treating Patients With Gliomas
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Organization Data
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Class:
NETWORK
Study ID:
EORTC-16011-26013
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None